Loading…
Wednesday, May 15 • 11:30am - 11:45am
Semaglutide: A Peptide Provides Hope

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Semaglutide has been approved as a weight loss treatment for nearly a decade. This peptide shows promising effects for substance and behavioral addictions too. This session will review emerging evidence and therapeutic potential of this GLP-1 receptor agonist. 

Speakers
avatar for Warren K. Bickel, Ph.D.

Warren K. Bickel, Ph.D.

Virginia Tech Carilion Behavioral Health Research Professor, Director, Addiction Recovery Research Center, Director, Center for Health Behaviors Research, Fralin Biomedical Research Institute at Virginia Tech Carilion
Dr. Bickel is an accomplished scholar and researcher in addiction and health behavior research. He received his Ph.D. in developmental and child psychology from the University of Kansas and completed post-doctoral training at Johns Hopkins University School of Medicine. He has led... Read More →


Wednesday May 15, 2024 11:30am - 11:45am EDT
Feedback form isn't open yet.